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Food allergies affect 5-10% of infants, 2-5% of toddlers,
and 1.3-2.6% of school children in Japan. Egg, milk and
wheat are the major three food allergens. Soybean is
one of the eight foods causing immediate allergic reac-
tions, sometimes anaphylaxis. Fermented soybeans, miso
and shoyu, are used in most of the traditional Japanese
foods, and exposure to soybeans in Japanese children
begins as one of the first solid foods, typically in the
form of tofu. Sensitization to soy, milk and wheat occurs
in many atopic babies. Some are the primary sensitiza-
tions to the foods through oral or cutaneous route, but
o t h e r sm a yb et h es e c o n d a r ys e n s i t i z a t i o nt h r o u g h
cross-reactive foods or pollens.
Component-specific IgE tests provide us more sensi-
tive and specific diagnostic tools. We have found that
casein, one of the most classically known allergen com-
ponents in milk, can be a more specific marker in the
diagnosis of milk allergy, especially in the older children.
Recombinant ω-5 gliadin ImmunoCAP
® provides almost
100 % positive predictive value of immediate type wheat
allergy in children at 17.5 kUA/L, as well as wheat-
dependent exercise-induced anaphylaxis in adults. Gly
m 5 and Gly m 6 from soybean can be a marker of
severe primary soy allergy in Japanese children. On the
other hands, patients with secondary soy allergy in
adults, who have allergic reactions exclusively to soy
milk, but not to tofu, are predominantly sensitized to
Gly m 4 (PR-10), possibly due to the cross-reactive pol-
len allergens.
In conclusion, allergen component testing is an excel-
lent clinical tool from a diagnostic point of view but
also provide us with new insights into food allergy.
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